66 results
Page 2 of 4
8-K
EX-99.1
3mm9 0co5d4dfbd0k7
2 Mar 21
Regulation FD Disclosure
8:00am
8-K
EX-99.2
2xyscactpd36oz0fxe
19 Nov 20
Aravive Announces Phase 3 Trial Design for AVB-500 in Platinum Resistant Ovarian Cancer
7:10am
8-K
EX-99.1
u08j108lls8e6
8 Oct 20
Regulation FD Disclosure
5:01pm
8-K
EX-1.1
8la9j5wbm9odwax
27 Nov 19
Aravive Announces Proposed Public Offering of Common Stock
4:15pm
424B5
qwpa50hkh
27 Nov 19
Prospectus supplement for primary offering
4:07pm
424B5
xg01jncsslnwpp7a
26 Nov 19
Prospectus supplement for primary offering
5:18pm
424B5
tugzz
26 Mar 19
Prospectus supplement for primary offering
6:25am
8-K
EX-1.1
5q48c4a55v
26 Mar 19
Entry into a Material Definitive Agreement
6:07am
S-4
3su4h0y
3 Aug 18
Registration of securities issued in business combination transactions
5:26pm